LL-BMT1

· MediPrint Ophthalmics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LL-BMT1, covering 2022-05-10 to 2022-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of LL-BMT1 in Patients With Elevated Intraocular Pressure [Phase 2]